EXERCISE AND ONCOLOGY PATIENTS

Dr Anthony Sung is an assistant professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy and associate director of the Duke Microbiome Center at the Duke University School of Medicine in Durham, North Carolina, US. He received his medical degree from Harvard Medical School in Boston, Massachusetts, US. Dr Sung completed his residency in internal medicine at Johns Hopkins Hospital in Baltimore, Maryland, US, and fellowship at Duke University School of Medicine. His current research interests include hematopoietic stem cell transplantation (HCT), with a focus on preventing complications such as infections, gastrointestinal toxicity, and graft-versus host disease through modulation of the microbiome; delivery of care, such as home-based HCT and mHealth, medication adherence, and behavioral economic incentives; costs associated with HCT; and novel cellular therapies. Dr Sung’s research encompasses murine, phase 1, phase 2, and correlative studies. He has authored/coauthored numerous articles published in peer-reviewed journals and presented his research at several conferences.